Enanta Pharmaceuticals (ENTA) Depreciation & Amortization (CF) (2012 - 2026)
Enanta Pharmaceuticals posted quarterly Depreciation & Amortization (CF) of $1.2 million for Q1 2026, little changed year-on-year from $1.2 million in Q1 2025, and down 1.71% on a QoQ basis from $1.2 million in Q4 2025.
Enanta Pharmaceuticals (ENTA) has 15 years of Depreciation & Amortization (CF) data on file, last reported at $1.2 million in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) changed 0.5% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $4.9 million (up 55.86% YoY), and the FY2025 full-year result was $4.6 million, up 96.32% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $1.2 million, down from $1.2 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $1.3 million in Q3 2025 and bottomed at $479000.0 in Q3 2024.
- The 5-year median for Depreciation & Amortization (CF) is $669000.0 (2023), against an average of $819117.6.
- The widest annual swing landed in 2022, when Depreciation & Amortization (CF) tumbled 34.49%; it then jumped 168.06% in 2025.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $511000.0 in 2022, then advanced by 25.64% to $642000.0 in 2023, then soared by 38.47% to $889000.0 in 2024, then jumped by 38.36% to $1.2 million in 2025, then retreated by 1.71% to $1.2 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $1.2 million (Q1 2026), $1.2 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | 1.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.21 Mn |
| Mar 31, 2026 | 1.21 Mn |
| Dec 31, 2025 | 1.23 Mn |
| Dec 31, 2025 | 1.23 Mn |
| Sep 30, 2025 | 1.28 Mn |
| Sep 30, 2025 | 1.28 Mn |
| Jun 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 1.21 Mn |
| Mar 31, 2025 | 1.20 Mn |
| Mar 31, 2025 | 1.20 Mn |
| Dec 31, 2024 | 889,000.00 |
| Dec 31, 2024 | 889,000.00 |
| Sep 30, 2024 | 479,000.00 |
| Sep 30, 2024 | 479,000.00 |
| Jun 30, 2024 | 594,000.00 |
| Jun 30, 2024 | 594,000.00 |
| Mar 31, 2024 | 621,000.00 |
| Mar 31, 2024 | 621,000.00 |
| Dec 31, 2023 | 642,000.00 |
| Dec 31, 2023 | 642,000.00 |
| Sep 30, 2023 | 669,000.00 |
| Sep 30, 2023 | 669,000.00 |
| Jun 30, 2023 | 651,000.00 |
| Jun 30, 2023 | 651,000.00 |
| Mar 31, 2023 | 540,000.00 |
| Mar 31, 2023 | 540,000.00 |
| Dec 31, 2022 | 511,000.00 |
| Dec 31, 2022 | 511,000.00 |
| Sep 30, 2022 | 655,000.00 |
| Sep 30, 2022 | 655,000.00 |
| Jun 30, 2022 | 716,000.00 |
| Jun 30, 2022 | 716,000.00 |
| Mar 31, 2022 | 822,000.00 |
| Mar 31, 2022 | 822,000.00 |
| Dec 31, 2021 | 780,000.00 |
| Dec 31, 2021 | 780,000.00 |
| Sep 30, 2021 | 806,000.00 |
| Sep 30, 2021 | 806,000.00 |
| Jun 30, 2021 | 823,000.00 |
| Jun 30, 2021 | 823,000.00 |
| Mar 31, 2021 | 834,000.00 |
| Mar 31, 2021 | 834,000.00 |
| Dec 31, 2020 | 871,000.00 |
| Dec 31, 2020 | 871,000.00 |
| Sep 30, 2020 | 909,000.00 |
| Sep 30, 2020 | 909,000.00 |
| Jun 30, 2020 | 916,000.00 |
| Jun 30, 2020 | 916,000.00 |
| Mar 31, 2020 | 915,000.00 |
| Mar 31, 2020 | 915,000.00 |
| Dec 31, 2019 | 904,000.00 |
| Dec 31, 2019 | 904,000.00 |
| Sep 30, 2019 | 891,000.00 |
| Sep 30, 2019 | 891,000.00 |
| Jun 30, 2019 | 885,000.00 |
| Jun 30, 2019 | 885,000.00 |
| Mar 31, 2019 | 802,000.00 |
| Mar 31, 2019 | 802,000.00 |
| Dec 31, 2018 | 680,000.00 |
| Dec 31, 2018 | 680,000.00 |
| Sep 30, 2018 | 661,000.00 |
| Sep 30, 2018 | 661,000.00 |
| Jun 30, 2018 | 657,000.00 |
| Jun 30, 2018 | 657,000.00 |
| Mar 31, 2018 | 613,000.00 |
| Mar 31, 2018 | 613,000.00 |
| Dec 31, 2017 | 587,000.00 |
| Dec 31, 2017 | 587,000.00 |
| Sep 30, 2017 | 564,000.00 |
| Sep 30, 2017 | 564,000.00 |
| Jun 30, 2017 | 552,000.00 |
| Jun 30, 2017 | 552,000.00 |
| Mar 31, 2017 | 528,000.00 |
| Mar 31, 2017 | 528,000.00 |
| Dec 31, 2016 | 493,000.00 |
| Dec 31, 2016 | 493,000.00 |
| Sep 30, 2016 | 455,000.00 |
| Sep 30, 2016 | 455,000.00 |
| Jun 30, 2016 | 434,000.00 |
| Jun 30, 2016 | 434,000.00 |
| Mar 31, 2016 | 433,000.00 |
| Mar 31, 2016 | 433,000.00 |
| Dec 31, 2015 | 339,000.00 |
| Dec 31, 2015 | 339,000.00 |
| Sep 30, 2015 | 204,000.00 |
| Sep 30, 2015 | 204,000.00 |
| Jun 30, 2015 | 165,000.00 |
| Jun 30, 2015 | 165,000.00 |
| Mar 31, 2015 | 141,000.00 |
| Mar 31, 2015 | 141,000.00 |
| Dec 31, 2014 | 129,000.00 |
| Dec 31, 2014 | 129,000.00 |
| Sep 30, 2014 | 110,000.00 |
| Sep 30, 2014 | 110,000.00 |
| Jun 30, 2014 | 88,000.00 |
| Jun 30, 2014 | 88,000.00 |
| Mar 31, 2014 | 79,000.00 |
| Mar 31, 2014 | 79,000.00 |
| Dec 31, 2013 | 75,000.00 |
| Dec 31, 2013 | 75,000.00 |
| Sep 30, 2013 | 73,000.00 |
| Sep 30, 2013 | 73,000.00 |
| Jun 30, 2013 | 61,000.00 |
| Jun 30, 2013 | 61,000.00 |
| Mar 31, 2013 | 48,000.00 |
| Mar 31, 2013 | 48,000.00 |
| Dec 31, 2012 | 39,000.00 |
| Dec 31, 2012 | 39,000.00 |
| Sep 30, 2012 | 39,000.00 |
| Sep 30, 2012 | 39,000.00 |
| Jun 30, 2012 | 35,000.00 |
| Jun 30, 2012 | 35,000.00 |